This edition of the Research Video Series focusing on the HD Buzz article detailing Skyhawk’s 15-month data release this Fall. SKY-0515 is an investigational therapy being studied in a Phase1/2 trial in people with HD.
HDYO Research Video Series is sponsored by: uniQure, Ferrer, Prilenia, Neurocrine Biosciences, Teva Pharmaceutical, Skyhawk Therapeutics, Novartis, Wave Life Sciences, Roche, Alnylam and the Griffin Foundation.